Sudarshan Sukhani of s2analytics.com recommends buying Bajaj Finance with stop loss at Rs 2970 and target of Rs 3080, Berger Paints with stop loss at Rs 322 and target of Rs 327 and Hindustan Zinc with stop loss at Rs 272 and target of Rs 285.
Sudarshan Sukhani of s2analytics.com recommends selling Vedanta with stop loss at Rs 195 and target of Rs 188, Shriram Transport with stop loss at Rs 1080 and target of Rs 1025 and Bharat Forge with stop loss at Rs 480 and target of Rs 464.
Ashwani Gujral of ashwanigujral.com suggests selling Ceat with a target of Rs 126.
We expect 11 percent and 17 percent CAGRs over FY18-20 in revenue & earnings respectively.
Rajat Bose of rajatkbose.com recommends buying Cadila Healthcare with stop loss below Rs 350.80 for target of Rs 356.90 and Colgate Palmolive with stop loss below Rs 1259.90 for targets of Rs 1299 and Rs 1308.
Sudarshan Sukhani of s2analytics.com recommends buying UPL with stop loss at Rs 745 and target of Rs 770 and Titan Company with stop loss at Rs 906 and target of Rs 930.
The RSI also has bounced from the oversold zone and currently it has indicated a steep rise.
Sudarshan Sukhani of s2analytics.com suggests buying Maruti Suzuki with stop loss at Rs 7570 and target of Rs 7800, Century Textiles with stop loss at Rs 905 and target of Rs 965 and Cadila Healthcare with stop loss at Rs 354 and target of Rs 382.
Key resistance on the upside is 100-day moving average around 10,950 and mark of 11,085 which is 61.8 percent retracement of 1,700 points fall during September-October, said Shabbir Kayyumi of Narnolia Financial Advisors
The slowdown in production at Morgantown site could provide a window of opportunity to Mylan's peers
Valuation of the broad market continues to be on the higher side and needs to settle as earnings growth is likely to downgrade further, says Vinod Nair of Geojit Financial Services.
Amid global and domestic headwinds, the market is likely to remain volatile and investors should use the current fall to build a portfolio for the next 2-3 years, suggest experts.
Rahul Mohindar of viratechindia.com is of the view that one can sell Tata Consultancy Services with target of Rs 2085 and stop loss at Rs 2085 and buy Dr Reddy's Laboratories with target of Rs 2680 and stop loss at Rs 2460.
On the lower side, 11484 followed by 11436 would now be seen as immediate and crucial supports. At this juncture, a strategy would be to focus on individual pockets that are providing better trading opportunities, says Sameet Chavan of Angel Broking.
The daily and weekly strength indicator RSI and the momentum indicator Stochastic both are in a positive terrain which supports upside momentum to continue in the near term, says Rajesh Palviya of Axis Securities.
KPR Mill, Lupin, Cadila Healthcare and Torrent Power could give 4-7% return in the next 1 month.
Rajesh Agarwal of AUM Capital recommends buying Vedanta with stop loss at Rs 226 and target of Rs 236, Manpasand Beverages with stop loss at Rs 137 and target of Rs 148 and Albert David with stop loss at Rs 708 and target of Rs 765.
Mitessh Thakkar of mitesshthakkar.com suggests buying Balrampur Chini with a stop loss of Rs 76 and target of Rs 81, Bosch with a stop loss of Rs 20,900 and target of Rs 22,000 and Cadila Heathcare with a stop loss of Rs 412 and target of Rs 445.
Rajesh Agarwal of AUM Capital recommends buying JK Paper with stop loss at Rs 175 and target of Rs 187, Aurobindo Pharma with stop loss at Rs 735 and target of Rs 789 and Cadila Healthcare with stop loss at Rs 413 and target of Rs 435.
Rajesh Agarwal of AUM Capital recommends buying JSW Steel with stop loss at Rs 345 and target of Rs 368, Cadila Healthcare with stop loss at Rs 388 and target of Rs 410 and LIC Housing Finance with stop loss at Rs 563 and target of Rs 585.
For the week, largecap added 0.9 percent, midcap rose 1.51 percent, while smallcap was ended on flat note.
Prakash Gaba of prakashgaba.com suggests buying Asian Paints with target at Rs 1300 and stop loss at Rs 1263 and Dewan Housing Finance with target at Rs 660 and stop loss at Rs 635.
At a time when most companies are struggling to show a consistent track record of growth, these 13 stocks are priced to perfection at current levels in comparison to return on capital employed (RoCE).
"For the medium to long term, we are positive on financials and automobiles," says Siddharth Sedani of Anand Rathi
Post-correction, pharmaceutical companies are now available at reasonable valuations making them attractive to long term investors